Psychosis associated with medical marijuana: Risk vs. Benefits of medicinal cannabis use

American Journal of Psychiatry

Volumn 167, Issue 5, 2010, Pages 598-599

  Pierre, Joseph M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CANNABIS; QUETIAPINE;

AGGRESSIVENESS; ANXIETY; AUDITORY HALLUCINATION; CHRONIC PAIN; DELUSION; DRUG DEPENDENCE; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FOLLOW UP; HEALTH HAZARD; HIGH RISK POPULATION; HOSPITAL READMISSION; HUMAN; INSOMNIA; IRRITABILITY; LETTER; MILITARY SERVICE; POSTTRAUMATIC STRESS DISORDER; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOSIS; RESIDUAL SCHIZOPHRENIA; RISK BENEFIT ANALYSIS; SMOKING; SUBSTANCE ABUSE; TREMOR;

CANNABIS; HUMANS; MALE; PSYCHOSES, SUBSTANCE-INDUCED; STRESS DISORDERS, POST-TRAUMATIC; YOUNG ADULT;

EID: 77951800346     PISSN: 0002953X     EISSN: 15357228     Source Type: Journal    
DOI: 10.1176/appi.ajp.2010.09121762     Document Type: Letter

References (4)

1. Moore THM, Zammit S, Lingford-Hughes A, Barnes TRE, Jones PB, Burke M, Lewis G: Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review. Lancet 2007; 370:319-328 (Pubitemid 47094993)
2. Compton MT, Kelley ME, Ramsay CE, Pringle M, Goulding SM, Esterberg ML, Stewart T, Walker EF: Association of pre-onset cannabis, alcohol, and tobacco use with age at onset of prodrome and age at onset of psychosis in first-episode patients. Am J Psychiatry 2009; 166:1251-1257
3. Hall W: The adverse health effects of cannabis use: What are they, and what are their implications for policy? Int J Drug Policy 2009; 20:458-466
4. Di Forti M, Morgan C, Dazzan P, Pariante C, Modelli V, Marques TR, Hadley R, Luzi S, Russo M, Paparelli A, Butt A, Stilo SA, Wiffen B, Powell J, Murray RM: High-potency cannabis and the risk of psychosis. Br J Psychiatry 2009; 195:488-491